Clinical pharmacology in drug development
Dec 4, 2015
Intravenous belimumab is approved for the treatment of systemic lupus erythematosus; subcutaneous self-administration would enable greater patient access. This study assessed relative bioavailability, tolerability, and safety of 1 subcutaneous dose o...
This study provides the first physiological evidence of humans' ability to empathize with robot pain and highlights the difference in empathy for humans and robots. We performed electroencephalography in 15 healthy adults who observed either human- o...
BACKGROUND: The clinically used methods of pain diagnosis do not allow for objective and robust measurement, and physicians must rely on the patient's report on the pain sensation. Verbal scales, visual analog scales (VAS) or numeric rating scales (N...
European journal of pain (London, England)
Jun 11, 2015
BACKGROUND: Opioids are used for the treatment of pain. However, 30-50% of patients have insufficient effect to the opioid initially selected by the physician, and there is an urgent need for biomarkers to select responders to the most appropriate dr...
Considering the limitations of use and side effects of existing analgesics, the discovery of new analgesics is necessary. Venoms of organisms are an important source of analgesic peptides. In this study, using computational biology methods such as mo...
The accurate assessment of pain in clinical settings is challenging due to its subjective nature. In this study, we used functional near-infrared spectroscopy (fNIRS) to measure brain activity by detecting changes in blood oxygenation. Leveraging the...
Pain is common in middle-aged and older adults, has also been identified as a fall risk factor, whereas the mechanism of falls in pain is unclear. This study included 13,074 middle-aged and older adults from the China health and retirement longitudin...
BACKGROUND: The opioid epidemic in the United States remains a major public health concern, with opioid-related deaths increasing more than 8-fold since 1999. Chronic pain, affecting 1 in 5 US adults, is a key contributor to opioid use and misuse. Wh...
It is clear that artificial intelligence-based chatbots will be popular applications in the field of healthcare in the near future. It is known that more than 30% of the world's population suffers from chronic pain and individuals try to access the h...
Pain is a complex, multidimensional experience involving significant challenges in both diagnosis and management. While acute pain serves as a critical warning mechanism, chronic pain encompasses intricate biological, psychological, and social compon...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.